Find information on Migraine Cephalalgia diagnosis, including ICD-10 code G43.1, clinical documentation requirements, headache symptoms, and treatment options. Learn about migraine diagnosis criteria, differential diagnosis considerations, and best practices for healthcare professionals documenting migraine in medical records. Explore resources for accurate medical coding and billing related to migraine cephalalgia.
Also known as
Migraine
Covers various types of migraine headaches.
Other headache syndromes
Includes headaches that may resemble or coexist with migraine.
Headache
General code for headache, used if a more specific type is unknown.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the headache consistent with migraine criteria?
When to use each related code
| Description |
|---|
| Migraine headache |
| Tension-type headache |
| Cluster headache |
Q: How can I differentiate between migraine with aura and transient ischemic attack (TIA) in a clinical setting to ensure accurate diagnosis and avoid misdiagnosis?
A: Differentiating between migraine with aura and TIA can be challenging due to overlapping symptoms. Focus on key distinctions. TIA symptoms tend to be negative (e.g., numbness, weakness) and resolve quickly, usually within an hour, without the typical headache phase of migraine. Migraine aura, while also often visual, tends to develop more gradually (over minutes) and involve positive phenomena (e.g., scintillations, fortification spectra). Headache usually follows, though it can sometimes be delayed or absent. Thorough neurological examination, including assessment of visual fields and cranial nerves, is crucial. Consider neuroimaging (MRI or CT) if symptoms are atypical, onset is abrupt, or neurological deficits persist. A detailed patient history, including age, vascular risk factors, and prior migraine history, is essential. Explore how risk stratification tools can aid in differentiating these conditions. Learn more about specific aura characteristics that can help distinguish migraine from TIA.
Q: What are the evidence-based non-pharmacological treatment options for migraine management in adults, especially for patients who prefer avoiding medications or have contraindications to specific drugs?
A: Non-pharmacological treatments play an important role in migraine management, offering alternatives for patients unable or unwilling to use medication. Evidence supports several approaches. Cognitive behavioral therapy (CBT) and biofeedback have demonstrated efficacy in reducing migraine frequency and intensity. Mindfulness-based stress reduction and relaxation techniques can also be beneficial. Lifestyle modifications, including regular sleep, a balanced diet, and identification and avoidance of triggers (e.g., certain foods, stress), are often recommended as first-line interventions. Aerobic exercise, such as brisk walking or cycling, can also help reduce migraine burden. Consider implementing a comprehensive, multidisciplinary approach that combines these non-pharmacological options. Explore how patient education and self-management strategies can empower individuals to control their migraines effectively.
Patient presents with a complaint of migraine headache, characterized by severe, throbbing, unilateral head pain. The patient reports a history of migraine with aura, describing visual disturbances such as scintillating scotoma preceding the headache onset. Associated symptoms include photophobia, phonophobia, and nausea. The patient denies vomiting, fever, or neck stiffness. Pain is exacerbated by routine physical activity and relieved by rest and darkness. Family history is positive for migraine headaches. Neurological examination is unremarkable. Diagnosis of migraine cephalalgia (ICD-10 G43.1, migraine with aura; or G43.90, migraine unspecified, if aura is absent) is made based on patient history, symptom presentation, and absence of other neurological findings. Differential diagnoses considered include tension-type headache, cluster headache, and secondary headache disorders. Treatment plan includes administration of sumatriptan succinate for acute migraine relief and patient education on migraine triggers, preventative measures, and lifestyle modifications. Patient advised to maintain a headache diary to track frequency, severity, and duration of migraine attacks. Follow-up appointment scheduled to assess treatment efficacy and discuss potential prophylactic medication options if needed, such as topiramate or propranolol. Patient counseled on the importance of medication adherence and potential side effects.